[1]宋雨 李耘 马丽娜.老年人衰弱和射血分数保留性心力衰竭病理生理学机制的研究进展[J].心血管病学进展,2022,(1):38-40.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.010]
 SONG Yu,LI Yun,MA Lina.Pathophysiological Mechanisms of Frailty and Heart Failure with Preserved Ejection Fraction in the Elderly[J].Advances in Cardiovascular Diseases,2022,(1):38-40.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.010]
点击复制

老年人衰弱和射血分数保留性心力衰竭病理生理学机制的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年1期
页码:
38-40
栏目:
出版日期:
2022-01-25

文章信息/Info

Title:
Pathophysiological Mechanisms of Frailty and Heart Failure with Preserved Ejection Fraction in the Elderly
作者:
宋雨 李耘 马丽娜
(首都医科大学宣武医院老年医学科 国家老年疾病临床医学研究中心,北京100053)
Author(s):
SONG Yu LI Yun MA Lina
?Department of Geriatrics,Xuanwu Hospital,Capital Medical University,National Research Center for Geriatric Medicine,Beijing 100053,China)
关键词:
衰弱射血分数保留性心力衰竭炎症氧化应激
Keywords:
FrailtyHeart failure with preserved ejection fractionInflammationOxidative stress
DOI:
10.16806/j.cnki.issn.1004-3934.2022.01.010
摘要:
衰弱和射血分数保留性心力衰竭是具有密切关联的疾病,二者具有共通的病理生理学机制,如慢性炎症、氧化应激、内分泌代谢和神经激素调节异常等,通过上述多种潜在机制的相互作用加速了二者的疾病进程,从而共同导致老年患者的不良预后。目前针对衰弱及射血分数保留性心力衰竭的干预方式有限,尤其是药物治疗尚存在局限性,深入认识衰弱和射血分数保留性心力衰竭的病理生理学机制将有助于探索二者潜在的治疗靶点,以期改善老年患者的预后。
Abstract:
Frailty and heart failure with preserved ejection fraction (HFpEF) are closely related diseases that share common pathophysiological mechanisms,such as chronic inflammation,oxidative stress,abnormal endocrine metabolism and neurohormonal regulation,which interact with each other to accelerate the disease process and lead to the poor prognosis in elderly patients. The current interventions for frailty and HFpEF are limited,especially in terms of pharmacological treatment. An in-depth understanding of the pathophysiological mechanisms of frailty and HFpEF will help to explore potential therapeutic targets in order to improve the prognosis of elderly patients.

参考文献/References:

[1] Morley JE,Vellas B,van Kan GA,et al. Frailty consensus:a call to action[J]. J Am Med Dir Assoc, 2013,14(6):392-397.

[2] Warraich HJ,Kitzman DW,Whellan DJ,et al. Physical function,frailty,cognition,depression,and quality of life in hospitalized adults≥60 years with acute decompensated heart failure with preserved versus reduced ejection fraction[J]. Circ Heart Fail,2018,11(11):e005254.

[3] Ferrucci L,Fabbri E. Inflammageing:chronic inflammation in ageing,cardiovascular disease,and frailty[J]. Nat Rev Cardiol,2018,15(9):505-522.

[4] Velissaris D,Pantzaris N,Koniari I,et al. C-reactive protein and frailty in the elderly:a literature review[J]. J Clin Med Res,2017,9(6):461-465.

[5] Soysal P,Stubbs B,Lucato P,et al. Inflammation and frailty in the elderly:a systematic review and meta-analysis[J]. Ageing Res Rev,2016,31:1-8.

[6] Walston J,Fedarko N,Yang H,et al. The physical and biological characterization of a frail mouse model[J]. J Gerontol A Biol Sci Med Sci,2008,63(4):391-398.

[7] Jurk D,Wilson C,Passos JF,et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice[J]. Nat Commun,2014,2:4172.

[8] Tromp J,Westenbrink BD,Ouwerkerk W,et al. Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction[J]. J Am Coll Cardiol,2018,72(10):1081-1090.

[9] Paulus WJ,Tsch?pe C. A novel paradigm for heart failure with preserved ejection fraction:comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation[J]. J Am Coll Cardiol,2013,62(4):263-271.

[10] van Woerden G,Gorter TM,Westenbrink BD,et al. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction[J]. Eur J Heart Fail,2018,20(11):1559-1566.

[11] Christensen RH,von Scholten BJ,Lehrskov LL,et al. Epicardial adipose tissue:an emerging biomarker of cardiovascular complications in type 2 diabetes?[J]. Ther Adv Endocrinol Metab,2020,11:2042018820928824.

[12] Liu CK,Lyass A,Larson MG,et al. Biomarkers of oxidative stress are associated with frailty:the Framingham Offspring Study[J]. Age (Dordr),2016,38 (1):1.

[13] Wu IC,Shiesh SC,Kuo PH,et al. High oxidative stress is correlated with frailty in elderly Chinese[J]. J Am Geriatr Soc,2009,57(9):1666-1671.

[14] de Gonzalo-Calvo D,de Luxán-Delgado B,Rodríguez-González S,et al. Oxidative protein damage is associated with severe functional dependence among the elderly population:a principal component analysis approach[J]. J Gerontol A Biol Sci Med Sci,2012,67(6):663-670.

[15] Deepa SS,van Remmen H,Brooks SV,et al. Accelerated sarcopenia in Cu/Zn superoxide dismutase knockout mice[J]. Free Radic Biol Med,2019,132:19-23.

[16] Dai DF,Chen T,Johnson SC,et al. Cardiac aging:from molecular mechanisms to significance in human health and disease[J]. Antioxid Redox Signal,2012,16(12):1492-1526.

[17] Dai DF,Chen T,Wanagat J,et al. Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria[J]. Aging Cell,2010,9(4):536-544.

[18] Dai DF,Rabinovitch PS. Cardiac aging in mice and humans:the role of mitochondrial oxidative stress[J]. Trends Cardiovasc Med,2009,19(7):213-220.

[19] Tanaka K,Wilson RM,Essick EE,et al. Effects of adiponectin on calcium-handling proteins in heart failure with preserved ejection fraction[J]. Circ Heart Fail,2014,7(6):976-985.

[20] Jacoby JJ,Kalinowski A,Liu MG,et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation,cardiac fibrosis,and heart failure with advanced age[J]. Proc Natl Acad Sci U S A,2003,100(22):12929-12934.

[21] Youm YH,Grant RW,Mccabe LR,et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging[J]. Cell Metab,2013,18(4):519-532.

[22] Butts B,Gary RA,Dunbar SB,et al. The importance of NLRP3 inflammasome in heart failure[J]. J Card Fail,2015,21(7):586-593.

[23] Kalyani RR,Varadhan R,Weiss CO,et al. Frailty status and altered glucose-insulin dynamics[J]. J Gerontol A Biol Sci Med Sci,2012,67(12):1300-1306.

[24] Yanagita I,Fujihara Y,Kitajima Y,et al. A high serum cortisol/DHEA-S ratio is a risk factor for sarcopenia in elderly diabetic patients[J]. J Endocr Soc,2019,3(4):801-813.

[25] Goldwater DS,Pinney SP. Frailty in advanced heart failure:a consequence of aging or a separate entity?[J]. Clin Med Insights Cardiol,2015,9( suppl 2):39-46.

[26] Ferrara N,Komici K,Corbi G,et al. β-adrenergic receptor responsiveness in aging heart and clinical implications[J]. Front Physiol,2014,4:396.

[27] Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling[J]. Cardiovasc Res,2004,63(3):423-432.

[28] Sukhanov S,Semprun-Prieto L,Yoshida T,et al. AngiotensinⅡ,oxidative stress and skeletal muscle wasting[J]. Am J Med Sci,2011,342 (2):143-147.

[29] Farooqi MAM,Gerstein H,Yusuf S,et al. Accumulation of deficits as a key risk factor for cardiovascular morbidity and mortality:a pooled analysis of 154 000 individuals[J]. J Am Heart Assoc,2020,9(3):e014686.

[30] Beldhuis IE,Myhre PL,Bristow M,et al. Spironolactone in patients with heart failure,preserved ejection fraction,and worsening renal function[J]. J Am Coll Cardiol,2021,77(9):1211-1221.

相似文献/References:

[1]孙慧雪 郑美芳 李海 孙磊 顾翔.远程医疗应用于射血分数保留性心力衰竭的现状及进展[J].心血管病学进展,2020,(3):251.[doi:10.16806/j.cnki.issn.1004-3934.20.03.009]
 SUN Huixue,ZHENG Meifang,LI Hai,et al.Status Progress of Telemedicine in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2020,(1):251.[doi:10.16806/j.cnki.issn.1004-3934.20.03.009]
[2]菲尔凯提·玉山江李昊穆叶赛·尼加提.射血分数保留性心力衰竭合并糖尿病的研究进展[J].心血管病学进展,2020,(4):373.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.011]
 FEIERKAITI·Yushanjiang,LIHao,MUYESAI.Nijiati.Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2020,(1):373.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.011]
[3]高可 杨蕾 姚新叶 郑小璞.射血分数保留性心力衰竭动物模型的研究进展[J].心血管病学进展,2020,(8):834.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.013]
 GAO Ke,YANG Lei,YAO Xinye,et al.Advances in Animal Models ofHeart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2020,(1):834.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.013]
[4]安子玉 梁颖慧 秦明照.高龄高血压患者降压治疗的相关问题[J].心血管病学进展,2021,(3):236.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.011]
 AN Ziyu,LIANG Yinghui,QIN Mingzhao.Antihypertensive Treatment in Very Elderly Patients with Hypertension[J].Advances in Cardiovascular Diseases,2021,(1):236.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.011]
[5]刘春秋 熊双 刘剑刚 董国菊.射血分数保留性心力衰竭的诊断的研究进展[J].心血管病学进展,2021,(9):784.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
 LIU Chunqiu,XIONG Shuang,LIU Jiangang,et al.Diagnosis of Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2021,(1):784.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[6]赵菲 刘永铭.抗炎类药物对射血分数保留性心力衰竭患者心外膜脂肪组织的影响[J].心血管病学进展,2022,(1):41.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.011]
 ZHAO Fei,LIU Yongming.Effects of Anti-Inflammatory Drugs on Epicardial Adipose Tissue in Patients with Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(1):41.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.011]
[7]张文珺 牛小伟 刘永铭.m6A甲基化在射血分数保留性心力衰竭中的作用的研究进展[J].心血管病学进展,2022,(1):44.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.012]
 ZHANG Wenjun,NIU Xiaowei,LIU Yongming.m6A RNA Methylation in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(1):44.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.012]
[8]聂琼 吴镜.射血分数保留性心力衰竭:从机制到治疗[J].心血管病学进展,2022,(3):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
 NIE Qiong,WU Jing.Heart Failure with Preserved Ejection Fraction:from Mechanism to Treatment[J].Advances in Cardiovascular Diseases,2022,(1):258.[doi:【DOI】10.16806/j.cnki.issn.1004-3934.2022.03.0170]
[9]卢甜甜 张轶.射血分数保留性心力衰竭左心室心肌力学变化及评估的研究进展[J].心血管病学进展,2022,(4):331.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.011]
 LU Tiantian,ZHANG Yi?/html>.Changes and Evaluation of Left Ventricular Myocardial Mechanical?n Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(1):331.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.011]
[10]时利英 蒋晖.运动训练在射血分数保留性心力衰竭的应用进展[J].心血管病学进展,2022,(4):344.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.014]
 SHI liying,JIANG hui.Exercise-Based Rehabilitation in Heart Failure with Preserved Ejection Fraction[J].Advances in Cardiovascular Diseases,2022,(1):344.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.014]

更新日期/Last Update: 2022-02-17